Results 1 to 10 of about 376,982 (341)

Isolated Prolongation of Activated Partial Thromboplastin Time: Not Just Bleeding Risk! [PDF]

open access: yesMedicina (Kaunas), 2023
Activated partial thromboplastin time (aPTT) is a fundamental screening test for coagulation disturbances. An increased aPTT ratio is quite common in clinical practice.
Santoro RC   +3 more
europepmc   +2 more sources

The partial thromboplastin (cephalin) time test [PDF]

open access: bronzeJournal of Clinical Pathology, 1972
Nine partial thromboplastin (cephalin) reagents have been compared in a parallel investigation of groups of patients on `long-term' anticoagulants, a group with moderate haemophilia, and patients on heparin infusion.Results with the seven commercial reagents and a human cephalin extract have been correlated with those of a specially prepared and ...
Jean M. Thomson, Leon Poller
openaire   +5 more sources

An Evaluation of the Activated Partial Thromboplastin Time Waveform [PDF]

open access: yesClinical and Applied Thrombosis/Hemostasis, 2017
The activated partial thromboplastin time (APTT) waveform includes several parameters that are related to various underlying diseases. The APTT waveform was examined in various diseases. Regarding the pattern of APTT waveform, a biphasic pattern of the first or second derivative curve (DC) was observed in patients with hemophilia and patients positive
Yoshiki Yamashita   +12 more
openaire   +4 more sources

Performance of Anti-Factor Xa Versus Activated Partial Thromboplastin Time for Heparin Monitoring Using Multiple Nomograms [PDF]

open access: hybridClinical and applied thrombosis/hemostasis, 2017
The purpose of this study was to compare the performance of anti-factor Xa concentration versus activated partial thromboplastin time (aPTT) monitoring with multiple indication-specific heparin nomograms.
Emily M. Whitman-Purves   +6 more
openalex   +2 more sources

An Evaluation of Hemostatic Abnormalities in Patients With Hemophilia According to the Activated Partial Thromboplastin Time Waveform [PDF]

open access: hybridClinical and applied thrombosis/hemostasis, 2018
The usefulness of the waveform of activated partial thromboplastin time (APTT) in various diseases has been evaluated in recent years. The APTT waveform was examined in patients with hemophilia and patients positive for lupus anticoagulant (LA).
Haruna Katayama   +10 more
openalex   +2 more sources

The Effect of Sugammadex on Prothrombin and Activated Partial Thromboplastin Time. [PDF]

open access: yesCureus, 2021
Sugammadex is routinely used as an effective neuromuscular blockade reversal agent. Several studies have indicated that it may prolong the prothrombin time (PT) and the activated partial thromboplastin time (aPTT). This review gathers the relevant in vivo studies to accumulate knowledge on the subject. Nine studies were included.
Samara E   +3 more
europepmc   +5 more sources

The multiple faces of the partial thromboplastin time APTT [PDF]

open access: bronzeJournal of Thrombosis and Haemostasis, 2004
S I, Rapaport   +7 more
  +11 more sources

Evaluation of Activated Partial Thromboplastin Time and Prothrombin Time in HIV and TB Patients in Owerri Metropolis

open access: yesJournal of Pharmaceutical Research International, 2022
Background: Human immunodeficiency Virus (HIV) and Tuberculosis (TB) are the leading infectious diseases with high morbidity and mortality in the developing countries; it has been known to be associated with some coagulation abnormalities especially as ...
I. L. Okoroiwu   +3 more
semanticscholar   +1 more source

Role of thromboelastography in the evaluation of septic shock patients with normal prothrombin time and activated partial thromboplastin time

open access: yesScientific Reports, 2021
Coagulopathy is frequent in septic shock and plays a key role in multiple organ dysfunction. The aim of this study is to investigate application values of thromboelastography (TEG) for outcome in septic shock patients with a normal value of prothrombin ...
Sang-Min Kim   +9 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy